Jazz Pharma has dipped its toe into the M&A water again, agreeing to buy epilepsy drug developer Actio Biosciences in a deal ...

Novo Nordisk has joined forces with Amazon Web Services (AWS) on a project that will lead to the creation of an AI ...

Ex-BioNTech chief strategy officer Ryan Richardson is chief executive of the new outfit, which launches with $25 million in seed financing led by Redmile, Vsquared Ventures and Kindred Capital.

The EU’s Joint Clinical Assessment (JCA), introduced 12th January 2025 under the EU Health Technology Assessment (HTA) ...

The Sweden-headquartered group is paying $75 million upfront to France's Innate in order to partner lacutamab, which is vying ...

The team at the Mass General Brigham Neuroscience Institute found that fewer than 3% of 267 people with Alzheimer's assessed ...

Topline results from the phase 3 LEVEL trial of TNX-103, an oral formulation of calcium sensitiser levosimendan, showed that the drug was unable to improve how far patients with pulmonary hypertension ...

Thousand Oaks, California startup Latigo, trading under the LTGO ticker, also landed an impressive sum in its IPO, selling 19 ...

For an emerging biopharma company developing an innovative therapy for a rare condition, 2026 presents a dilemma that may ...

Takeda's orexin agonist Orzeyful has been approved in the US to treat narcolepsy type 1 (NT1) in adults, becoming the first ...

Sentiment towards Novo Nordisk was also hit by the acknowledgement that it has decided to abandon the development of ...

The National Medical Products Administration (NMPA) has cleared Yochanra (tinengotinib) for adult patients with unresectable ...